These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 28953851)

  • 41. Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: the search for a valid target.
    Lipsman N; Neimat JS; Lozano AM
    Neurosurgery; 2007 Jul; 61(1):1-11; discussion 11-3. PubMed ID: 17621014
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A review of brain stimulation methods to treat substance use disorders.
    Coles AS; Kozak K; George TP
    Am J Addict; 2018 Mar; 27(2):71-91. PubMed ID: 29457674
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Right prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
    Alonso P; Pujol J; Cardoner N; Benlloch L; Deus J; Menchón JM; Capdevila A; Vallejo J
    Am J Psychiatry; 2001 Jul; 158(7):1143-5. PubMed ID: 11431238
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of serotonin transporter gene on rTMS augmentation of SSRIs for obsessive compulsive disorder.
    Zhang K; Fan X; Yuan J; Yin J; Su H; Hashimoto K; Wang G
    Neuropsychiatr Dis Treat; 2019; 15():1771-1779. PubMed ID: 31308670
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment strategies for obsessive-compulsive disorder.
    Marazziti D; Consoli G
    Expert Opin Pharmacother; 2010 Feb; 11(3):331-43. PubMed ID: 20102301
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Repetitive transcranial magnetic stimulation for the treatment of obsessive compulsive disorder: a double-blind controlled investigation.
    Sachdev PS; Loo CK; Mitchell PB; McFarquhar TF; Malhi GS
    Psychol Med; 2007 Nov; 37(11):1645-9. PubMed ID: 17655805
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety and efficacy of early augmentation with repetitive transcranial magnetic stimulation in the treatment of drug-free patients with obsessive-compulsive disorder.
    Joshi M; Kar SK; Dalal PK
    CNS Spectr; 2022 Jan; ():1-7. PubMed ID: 35082003
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transcranial direct current stimulation for treatment-resistant obsessive-compulsive disorder-A large case series.
    Thamby A; Seshachala K; Sharma L; Thimmashetty VH; Balachander S; Shivakumar V; Hazari N; Chhabra H; Arumugham SS; Ts J; K M; Venkatasubramanian G; Reddy YCJ; Narayanaswamy JC
    Asian J Psychiatr; 2021 Jun; 60():102625. PubMed ID: 33930710
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and tolerability of repetitive transcranial magnetic stimulation for the treatment of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis.
    Liang K; Li H; Bu X; Li X; Cao L; Liu J; Gao Y; Li B; Qiu C; Bao W; Zhang S; Hu X; Xing H; Gong Q; Huang X
    Transl Psychiatry; 2021 May; 11(1):332. PubMed ID: 34050130
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Deep TMS add-on treatment for intractable Tourette syndrome: A feasibility study.
    Bloch Y; Arad S; Levkovitz Y
    World J Biol Psychiatry; 2016 Oct; 17(7):557-61. PubMed ID: 25342253
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Transcranial direct current stimulation (tDCS) for obsessive-compulsive disorder: A new treatment option?].
    Palm U; Brunelin J; Wulf L; Mondino M; Brunoni AR; Padberg F
    Fortschr Neurol Psychiatr; 2020 Jul; 88(7):451-458. PubMed ID: 30537770
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Non-invasive brain stimulation for Parkinson's disease: Current concepts and outlook 2015.
    Benninger DH; Hallett M
    NeuroRehabilitation; 2015; 37(1):11-24. PubMed ID: 26409690
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polarity-dependent effects of transcranial direct current stimulation in obsessive-compulsive disorder.
    D'Urso G; Brunoni AR; Anastasia A; Micillo M; de Bartolomeis A; Mantovani A
    Neurocase; 2016; 22(1):60-4. PubMed ID: 25971992
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transcranial direct current stimulation in obsessive-compulsive disorder: an update in electric field modeling and investigations for optimal electrode montage.
    da Silva RMF; Batistuzzo MC; Shavitt RG; Miguel EC; Stern E; Mezger E; Padberg F; D'Urso G; Brunoni AR
    Expert Rev Neurother; 2019 Oct; 19(10):1025-1035. PubMed ID: 31244347
    [No Abstract]   [Full Text] [Related]  

  • 55. Transcranial Direct Current Stimulation in Psychiatric Disorders: A Comprehensive Review.
    Moffa AH; Brunoni AR; Nikolin S; Loo CK
    Psychiatr Clin North Am; 2018 Sep; 41(3):447-463. PubMed ID: 30098657
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Repetitive transcranial magnetic stimulation in the treatment of obsessive-compulsive disorders: Double blind randomized clinical trial.
    Elbeh KAM; Elserogy YMB; Khalifa HE; Ahmed MA; Hafez MH; Khedr EM
    Psychiatry Res; 2016 Apr; 238():264-269. PubMed ID: 27086243
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacological, experimental therapeutic, and transcranial magnetic stimulation treatments for compulsivity and impulsivity.
    Pallanti S; Hollander E
    CNS Spectr; 2014 Feb; 19(1):50-61. PubMed ID: 24176028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adjunctive high-frequency right prefrontal repetitive transcranial magnetic stimulation (rTMS) was not effective in obsessive-compulsive disorder but improved secondary depression.
    Sarkhel S; Sinha VK; Praharaj SK
    J Anxiety Disord; 2010 Jun; 24(5):535-9. PubMed ID: 20392594
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deep brain stimulation for obsessive-compulsive disorder: subthalamic nucleus target.
    Chabardès S; Polosan M; Krack P; Bastin J; Krainik A; David O; Bougerol T; Benabid AL
    World Neurosurg; 2013; 80(3-4):S31.e1-8. PubMed ID: 22469523
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS).
    Mantovani A; Lisanby SH; Pieraccini F; Ulivelli M; Castrogiovanni P; Rossi S
    Int J Neuropsychopharmacol; 2006 Feb; 9(1):95-100. PubMed ID: 15982444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.